Dose-dependent association of inflammatory cytokines with carotid atherosclerosis in transient ischaemic attack: Implications for clinical trials
S Coveney, JJ McCabe, S Murphy, O Belton… - Cerebrovascular …, 2022 - karger.com
Introduction: The 5-year recurrence risk after ischaemic stroke and transient ischaemic
attack (TIA) is 25–30%. Although inflammation may be a target for prevention trials, the …
attack (TIA) is 25–30%. Although inflammation may be a target for prevention trials, the …
Dose-Dependent Association of Inflammatory Cytokines with Carotid Atherosclerosis in Transient Ischaemic Attack: Implications for Clinical Trials.
S Coveney, JJ McCabe, S Murphy, O Belton… - Cerebrovascular …, 2021 - europepmc.org
Methods Blood and Imaging markers of TIA BIO-TIA) is a multicentre prospective study of
imaging and inflammatory markers in patients with TIA. Exclusion criteria were infection and …
imaging and inflammatory markers in patients with TIA. Exclusion criteria were infection and …
Dose-Dependent Association of Inflammatory Cytokines with Carotid Atherosclerosis in Transient Ischaemic Attack: Implications for Clinical Trials
S Coveney, JJ McCabe, S Murphy… - Cerebrovascular …, 2022 - pubmed.ncbi.nlm.nih.gov
Introduction The 5-year recurrence risk after ischaemic stroke and transient ischaemic attack
(TIA) is 25-30%. Although inflammation may be a target for prevention trials, the contribution …
(TIA) is 25-30%. Although inflammation may be a target for prevention trials, the contribution …
Dose-Dependent Association of Inflammatory Cytokines with Carotid Atherosclerosis in Transient Ischaemic Attack: Implications for Clinical Trials.
S Coveney, JJ McCabe, S Murphy… - Cerebrovascular …, 2022 - search.ebscohost.com
Introduction: The 5-year recurrence risk after ischaemic stroke and transient ischaemic
attack (TIA) is 25–30%. Although inflammation may be a target for prevention trials, the …
attack (TIA) is 25–30%. Although inflammation may be a target for prevention trials, the …
Dose-Dependent Association of Inflammatory Cytokines with Carotid Atherosclerosis in Transient Ischaemic Attack: Implications for Clinical Trials
S Coveney, JJ McCabe, S Murphy, O Belton… - Cerebrovascular …, 2022 - karger.com
Introduction: The 5-year recurrence risk after ischaemic stroke and transient ischaemic
attack (TIA) is 25–30%. Although inflammation may be a target for prevention trials, the …
attack (TIA) is 25–30%. Although inflammation may be a target for prevention trials, the …